Clinical Trial Update: Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of intranasal TBS-1 for male hypogonadism has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Male Hypogonadism

Drugs mentioned

• TBS-1 intranasal (TBS-1)

Snippet

Sponsor: Acerus Pharmaceuticals Corporation | Conditions: Male Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2018-06-13